Methotrexate is a type of medicine used to treat certain cancers and autoimmune diseases. It works by stopping cancer cells from growing and multiplying. It also helps reduce inflammation in conditions like rheumatoid arthritis.
Every report comes from a Lived member, sent anonymously.
Have you tried Methotrexate for Rheumatoid Arthritis?
Methotrexate is a prescription medicine with two quite different roles. At low doses taken once a week, it is one of the most widely used long-term treatments for rheumatoid arthritis, an autoimmune disease in which the immune system attacks the joints. It is also approved for polyarticular juvenile idiopathic arthritis (pJIA), a form of childhood arthritis that affects five or more joints, and for severe psoriasis in adults. In these conditions it is a disease-modifying drug: the aim is to calm the underlying disease and limit long-term joint or skin damage, not simply to ease pain. At higher or differently scheduled doses, methotrexate is a chemotherapy drug. It is part of treatment for acute lymphoblastic leukemia in children and adults, and is used for certain lymphomas, osteosarcoma (a bone cancer), breast cancer, some head and neck cancers and gestational trophoblastic neoplasia, a rare tumor that grows from pregnancy tissue. Doctors also use it outside its formal approvals, for example in Crohn's disease, and as a nonsurgical treatment for some ectopic pregnancies found early. For rheumatoid arthritis, the American College of Rheumatology recommends methotrexate as the usual first disease-modifying drug, ahead of alternatives such as hydroxychloroquine or sulfasalazine and ahead of starting with a biologic medicine (an injected or infused medicine that targets a specific part of the immune system). The reasons are its established effectiveness, long safety record and low cost, and many people reach their treatment goal on methotrexate alone. When it is not enough, other medicines are often added to it rather than replacing it. Methotrexate is sold as generic tablets and under several brand names: Trexall (tablets), Xatmep and Jylamvo (oral liquids), and Otrexup and Rasuvo (once-weekly auto-injector pens for arthritis and psoriasis, not for cancer). Clinics and hospitals also give it by injection.
Every cell needs folate, a B vitamin, to build new DNA. Methotrexate blocks an enzyme called dihydrofolate reductase, which converts folate into the form cells can use. Cells that divide quickly depend most on that supply, so they are affected most: cancer cells, but also bone marrow and the lining of the mouth and gut. This explains both its anticancer effect and some of its typical side effects, such as mouth sores and low blood counts. At the much lower weekly doses used for arthritis and psoriasis, methotrexate calms overactive immune activity and, in psoriasis, slows the overgrowth of skin cells. Exactly how it does this in these conditions is not known. Its effect builds gradually over weeks, so it does not work like a painkiller that brings relief within hours.
How methotrexate is taken depends on what it is treating. For rheumatoid arthritis, juvenile arthritis and psoriasis, it is taken once a week, on the same day each week, as tablets, an oral liquid or an injection under the skin. Treatment usually starts at a low weekly dose that is raised gradually until the disease is controlled. Some people move from tablets to injections; the body absorbs the two forms differently, so the prescriber sets the new dose rather than converting it milligram for milligram. The oral liquids are measured with the syringe supplied, not a kitchen spoon. The once-weekly schedule is the most important safety point. Taking weekly methotrexate every day by mistake has caused deaths. Choosing a fixed day, marking it on a calendar or pill organizer and making sure anyone who helps with medicines knows the schedule all reduce that risk. If extra doses have been taken by mistake, call Poison Control at 1-800-222-1222 or the prescriber right away, even if there are no symptoms yet. If a dose is missed, call the prescriber for advice and do not take a double dose. People taking methotrexate for arthritis or psoriasis are usually prescribed folic acid or folinic acid (leucovorin, an active form of folate) as well, to lower the risk of side effects. In cancer treatment the opposite applies: folic acid products can make methotrexate less effective, so they should be taken only if the oncology team says so. Cancer treatment uses schedules and doses set by the oncology team as part of a wider regimen. These range from weekly tablets during leukemia maintenance to injections into a vein, a muscle or the fluid around the spinal cord.
The most common side effects are mouth sores, nausea, stomach discomfort and tiredness. Blood tests may show raised liver enzymes, which were the most frequent finding in rheumatoid arthritis studies (about 15 percent of people), or a lower white blood cell count. Hair thinning, headache, dizziness and increased sensitivity to sunlight can also occur. Taking folic acid as prescribed, and sometimes a dose change, often helps with milder problems. Methotrexate can seriously affect the bone marrow, liver, lungs, kidneys, gut and skin, which is why it is used with regular monitoring. Contact the care team right away for any of the following. Fever, chills, a sore throat or unusual bruising or bleeding can mean low blood counts and a weakened defense against infection. A new dry cough or shortness of breath can be a sign of lung inflammation (pneumonitis). Yellowing of the skin or eyes or pain in the upper right abdomen can point to liver injury. Mouth sores that make eating difficult, new or worsening diarrhea, or black or bloody stools need assessment, as does a rash with blisters, peeling skin or fever. Rarely, methotrexate affects the nervous system; confusion, a seizure, sudden vision loss or weakness on one side of the body needs urgent medical attention. Over years of use, methotrexate can cause liver scarring, sometimes without symptoms. Liver blood tests continue for as long as treatment does, but they do not always show scarring, so the care team may order other checks. It has also been linked to other cancers, including lymphoma and skin cancer.
Methotrexate can cause serious birth defects and fetal death. It must not be used during pregnancy for arthritis, psoriasis or other non-cancer conditions, and pregnancy is ruled out before it is started. People who could become pregnant need effective birth control during treatment and for 6 months after the last dose. Men whose partners could become pregnant should use contraception during treatment and for 3 months afterward. If pregnancy occurs, contact the prescriber right away. Breastfeeding is not advised during treatment or for 1 week after the last dose. Methotrexate can also reduce fertility in both men and women, including lowering sperm count and disrupting periods. Several common medicines can raise methotrexate levels or add to its toxicity. These include aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen; some antibiotics, including penicillins and sulfa antibiotics; proton pump inhibitors, the acid-reducing medicines for heartburn such as omeprazole (Prilosec); and other medicines that strain the liver or kidneys. Many people with arthritis take an NSAID alongside low-dose methotrexate with their prescriber's knowledge, so the practical step is to tell every prescriber, dentist and pharmacist about methotrexate before anything new is started. Nitrous oxide (laughing gas) anesthesia should be avoided, which matters before surgery or dental work. Heavy drinking raises the risk of liver damage, and existing liver or kidney disease, lung disease, stomach ulcers or ulcerative colitis can make side effects more likely. Because methotrexate weakens the immune system, the prescriber should know about any past hepatitis B, tuberculosis or shingles, which can flare up again. Live vaccines are not recommended during treatment, so it is best to update vaccinations before starting. Sun exposure can worsen psoriasis while taking methotrexate, so sun protection is advised.
For rheumatoid arthritis and juvenile arthritis, improvement usually begins 3 to 6 weeks after starting, and benefit can keep building for 12 weeks or more as the dose is adjusted. If methotrexate alone does not control the disease well enough, another medicine is often added to it. Blood tests to check blood counts, liver function and kidney function are done before starting and regularly throughout treatment. Their purpose is to catch side effects early, before they become severe, so keeping lab appointments is part of taking methotrexate safely. For arthritis and psoriasis, methotrexate is usually a long-term treatment, continued while it works and is tolerated, even when someone feels well. In psoriasis, the dose is typically lowered to the smallest amount that keeps the skin under control. Changes or stopping should be planned with the prescriber. A person who could become pregnant should plan with the prescriber to stop methotrexate well before trying to conceive, because the label advises waiting 6 months after the last dose. A man planning to father a child should ask the prescriber whether to continue or pause it: the label advises waiting 3 months, but rheumatology guidance allows many men on low-dose methotrexate to keep taking it. In cancer treatment, the length and intensity of methotrexate depend on the overall regimen.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Methotrexate, what you've noticed, or ask the community a question.